Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Lactobacillus salivarius

ProbioticPantetheineBest before bed

Useful mainly for people trying a probiotic for oral/gum health or general gut support.

Quick decision guide

May help most

people trying a probiotic for oral/gum health or general gut support

Common dosing range

1–10 billion CFU/day; oral lozenges 100 million–1 billion CFU

When to expect effects

Weeks

Watch out for

Rare bacteremia risk in immunocompromised or critically ill people

What is it

Lactobacillus salivarius is a probiotic bacterium found naturally in the mouth, small intestine, and vagina. It is used in supplements and oral care products for digestive, oral, and immune health, with several specific strains commercially available.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want to trial a probiotic for gum health or halitosis (as a lozenge)

You are looking for general gut support

You can choose a product with a documented strain

Probably skip if…

You expect it to replace dental care or treat established periodontitis

You are severely immunocompromised or critically ill

You want strong, condition-specific proof of benefit

Evidence at a glance

Goal	Effect	Best fit	Time
oral health and halitosis Limited Evidence	Modest in small studies	adults using strain-specific oral lozenges for bad breath	Weeks
gingivitis and periodontal health Limited Evidence	Modest as an adjunct	adults using it alongside standard oral hygiene	Weeks
pediatric atopic dermatitis Limited Evidence	Uncertain	children with atopic dermatitis under clinician guidance	Weeks to months
functional gastrointestinal symptoms Mixed Evidence	Uncertain	adults with mild functional GI complaints	Weeks

oral health and halitosis

Limited Evidence

Effect: Modest in small studies
Best fit: adults using strain-specific oral lozenges for bad breath
Time: Weeks

gingivitis and periodontal health

Limited Evidence

Effect: Modest as an adjunct
Best fit: adults using it alongside standard oral hygiene
Time: Weeks

pediatric atopic dermatitis

Limited Evidence

Effect: Uncertain
Best fit: children with atopic dermatitis under clinician guidance
Time: Weeks to months

functional gastrointestinal symptoms

Mixed Evidence

Effect: Uncertain
Best fit: adults with mild functional GI complaints
Time: Weeks

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

oral health and halitosis

Supplement benefit

Limited Evidence

Certain L. salivarius strains produce lactic acid and antimicrobial salivaricins that can suppress odor-producing and cavity-associated oral bacteria. Small trials of oral lozenges suggest modest reductions in halitosis and oral pathogen counts. Evidence is preliminary and highly strain-dependent.

Effect size

Modest in small studies

Time to effect

Weeks

Best fit

adults using strain-specific oral lozenges for bad breath

Bottom line: Strain-specific lozenges may modestly help bad breath, but evidence is limited.

SourceMousquer et al., 2020 — PubMed Suzuki et al., 2014 — PubMed

gingivitis and periodontal health

Supplement benefit

Limited Evidence

Some small studies report that L. salivarius lozenges modestly reduce gingival inflammation and plaque indices when added to routine oral care. It is an adjunct, not a replacement for brushing, flossing, or professional treatment. Trials are small and use varied strains and endpoints.

Effect size

Modest as an adjunct

Time to effect

Weeks

Best fit

adults using it alongside standard oral hygiene

Less likely

people with advanced periodontitis expecting standalone treatment

Bottom line: A possible adjunct for gum health, but not a substitute for dental care.

Evidence is mixed

Periodontal trials are small and inconsistent, and benefits vary by strain and study design.

SourceShimauchi et al., 2008 — PubMed· conflicting NĘdzi-GÓra et al., 2020 — PMC· conflicting

SourceShimauchi et al., 2008 — PubMed NĘdzi-GÓra et al., 2020 — PMC

pediatric atopic dermatitis

Disease adjunct

Limited Evidence

A few pediatric trials have explored L. salivarius for atopic dermatitis, with some reporting improvement in severity scores. The number of studies is small and results are not consistent enough to recommend it broadly. Use in children should involve a clinician.

Effect size

Uncertain

Time to effect

Weeks to months

Best fit

children with atopic dermatitis under clinician guidance

Bottom line: Preliminary pediatric evidence only; not an established eczema treatment.

Evidence is mixed

The small pediatric atopic dermatitis trials are not consistently positive.

SourceWu et al., 2012 — PubMed· conflicting Drago et al., 2011 — PubMed· conflicting

SourceWu et al., 2012 — PubMed Drago et al., 2011 — PubMed

functional gastrointestinal symptoms

Supplement benefit

Mixed Evidence

L. salivarius adheres to intestinal cells and may compete with less desirable bacteria and modulate immune signaling, providing a rationale for use in functional GI symptoms. Direct clinical evidence in conditions such as IBS is limited and strain-specific. Benefits, if any, appear modest.

Effect size

Uncertain

Time to effect

Weeks

Best fit

adults with mild functional GI complaints

Bottom line: Plausible but unproven for functional gut symptoms; effects are likely modest at best.

SourceO'Mahony et al., 2005 — PubMed

How it works

L. salivarius produces high quantities of lactic acid, lowering local pH and creating an environment less favorable for many pathogenic bacteria. It also produces salivaricins, antimicrobial peptides that can inhibit competing organisms, including those involved in dental decay and gum disease. In the gastrointestinal tract, L. salivarius adheres to intestinal epithelial cells and competes with potentially harmful bacteria for nutrients and binding sites. It interacts with the gut-associated immune system, modulating cytokine production and potentially supporting more balanced immune responses. Certain strains have been studied for their ability to strengthen intestinal barrier integrity and reduce inflammation. The oral cavity is a notable habitat for L. salivarius, and certain strains have been developed for use in oral lozenges and chewable tablets targeting halitosis, gum health, and reduction of cavity-causing Streptococcus mutans. Strain-specific effects are important: the documented uses of L. salivarius UCC118 (gut applications) differ from those of L. salivarius K12 (oral applications, though K12 is actually a Streptococcus species).

How to take it

1. Typical dose

1–10 billion CFU/day for gut use; 100 million–1 billion CFU per lozenge for oral use

2. Timing

Gut: with or after a small meal. Oral: lozenge after brushing, ideally before bed

3. With food

Gut use with a small meal may aid stomach survival; for oral use avoid eating/drinking for 30 minutes after

4. How long to try

Trial for several weeks

What to track

Gum bleeding or bad breath (oral use)

Digestive comfort

Any GI side effects when starting

3 commercial forms

Compare the main delivery options and what they’re best suited for.

L. salivarius UCC118

Used in gut-targeted supplements and research formulations.

Acid-stable, well-characterized gut strain

L. salivarius LS01

Used in supplements targeting skin and immune outcomes.

Studied in atopic dermatitis trials

L. salivarius (oral lozenge strains)

Used in dental and oral health products, often combined with other oral probiotics.

Designed for oral cavity adhesion

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild gas, bloating, or digestive changes initially

Serious risks

Rare bacteremia in immunocompromised or critically ill patients

Who should avoid it

Severely immunocompromised individuals
People with central venous catheters
Critically ill patients

Pregnancy & breastfeeding

Generally well tolerated in pregnancy and breastfeeding; check labels for dairy-based carriers if milk-allergic.

Interactions

Immunosuppressive medicationsModerate

May raise the small risk of bacterial translocation

Antibiotics (including oral antimicrobials)Minor

Can kill probiotic organisms; separate by at least 2 hours

Antiseptic mouthwashesMinor

Use after, not concurrent with, oral antiseptics for lozenge applications

Food sources

Food	Amount	%DV
Some fermented dairy products	Variable; not commonly added to standard yogurts	—
Naturally fermented foods	Variable presence; not standardized	—

Some fermented dairy products

Amount: Variable; not commonly added to standard yogurts
%DV: —

Naturally fermented foods

Amount: Variable presence; not standardized
%DV: —

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Specific strain designation and CFU count

Lozenge format for oral applications

Allergen statement for dairy carriers

Be skeptical of…

Replaces brushing or dental visits

Cures eczema or IBS

Unsupported immune-boosting claims

Frequently asked questions

Can L. salivarius improve bad breath?⌄

Some oral probiotic lozenges containing L. salivarius show modest reduction in volatile sulfur compounds responsible for halitosis. It works best when combined with good oral hygiene.

Should I take oral or capsule L. salivarius?⌄

Capsules target gut applications, while lozenges target the oral cavity. Capsule probiotics that pass through the mouth quickly do not effectively colonize the oral environment.

How long do oral L. salivarius effects last?⌄

Effects are temporary and depend on continued use. Stopping oral probiotic lozenges typically allows the previous oral microbiome to gradually return.

Can children use L. salivarius?⌄

L. salivarius has been used in pediatric trials and is generally well tolerated. Discuss specific applications with your pediatrician.

Is L. salivarius safe with antibiotics?⌄

Antibiotics can kill probiotic organisms. Separate doses by at least 2 hours. Taking L. salivarius during and after a course of antibiotics may help support digestive recovery.

References by claim

oral health and halitosis

Mousquer et al., 2020 — PubMed (2020) link

Suzuki et al., 2014 — PubMed (2014) link

gingivitis and periodontal health

Shimauchi et al., 2008 — PubMed (2008) link

NĘdzi-GÓra et al., 2020 — PMC (2020) link

pediatric atopic dermatitis

Wu et al., 2012 — PubMed (2012) link

Drago et al., 2011 — PubMed (2011) link

functional gastrointestinal symptoms

O'Mahony et al., 2005 — PubMed (2005) link

Track Lactobacillus salivarius with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.